Table 1

Surge in Anaplasmosis Cases in Maine, USA, 2013–2017

Susan P. Elias

, Jessica Bonthius, Sara Robinson, Rebecca M. Robich, Charles B. Lubelczyk, and Robert P. Smith

Author affiliations: Maine Medical Center Research Institute, Scarborough, Maine, USA (S.P. Elias, R.M. Robich, C.B. Lubelczyk, R.P. Smith, Jr.); University of Southern Maine, Portland, Maine, USA (J. Bonthius); Maine Center for Disease Control and Prevention, Augusta, Maine, USA (S. Robinson)

Main Article

Number of HGA and Lyme disease cases and incidence, Maine, USA, 2008–2017*

Year	HGA
	Cases				Incidence				Lyme
	All ages	0–17 y	18–64 y	>65 y	All ages	0–17 y	18–64 y	>65 y	Cases	Incidence†
2008	17	0	11	6	1.3	0	1.3	3.0	909	68.3
2009	15	0	9	6	1.1	0	1.1	2.9	976	73.4
2010	17	1	10	6	1.3	0.4	1.2	2.8	752	56.6
2011	26	0	12	14	2.0	0	1.4	6.5	1013	76.3
2012	52	0	37	15	3.9	0	4.4	6.6	1113	83.7
2013	94	0	56	38	7.1	0	6.7	16.2	1384	104.2
2014	191	10	102	79	14.4	3.9	12.3	32.5	1411	106.1
2015	185	9	92	84	13.9	3.5	11.2	33.6	1215	91.4
2016	372	9	206	157	27.9	3.5	25.2	60.8	1497	112.4
2017	663	13	304	346	49.7	5.1	37.3	129.6	1844	138.5
Change 2013–2017‡	605%		443%	811%	602%		454%	701%	33%	33%

*Case data provided by the Maine Center for Disease Control and Prevention. HGA, human granulocytic anaplasmosis.
†Cases/100,000 population.
‡Percentage increase 2013–2017 was calculated when there were nonzero data for 2013.

Main Article

Page created: January 20, 2020

Page updated: January 20, 2020

Page reviewed: January 20, 2020

The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.

Volume 26, Number 2—February 2020

Dispatch

Surge in Anaplasmosis Cases in Maine, USA, 2013–2017

Table 1